Report - colony-smyeloid leukemia (AML) (1.2) Reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies

Please pass captcha verification before submit form